Acetylation of Histone H3 in Cancer Progression and Prognosis

Paulina Miziak,Marzena Baran,Lidia Borkiewicz,Tomasz Trombik,Andrzej Stepulak
DOI: https://doi.org/10.3390/ijms252010982
IF: 5.6
2024-10-12
International Journal of Molecular Sciences
Abstract:Cancer is a multifactorial disease resulting from both genetic factors and epigenetic changes. Histone acetylation, a post-translational modification, which alters chromatin architecture and regulates gene expression is associated with cancer initiation, development and progression. Aberrations in global histone acetylation levels are observed in various cancer cells and are also associated with patients' tumor aggressiveness. Therefore, histone acetylation may have prognostic utility and serve as a potential biomarker of cancer progression and patients' prognosis. The reversible modification of histones by an acetyl group is versatile. One particular histone can be acetylated on different lysine residues, subsequently resulting in different biological outcomes. Here, we discuss recent findings on the acetylation of the highly conserved histone protein H3 in the context of cancer biology. Specifically, we review the acetylation of particular H3 residues in various cancer types. We further highlight the significance of H3 acetylation levels as a potential cancer biomarker with prognostic implications.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?